Short term blood pressure and metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes.
Feher
M D
MD
Department of Clinical Pharmacology, Charing Cross and Westminster Medical School, London, UK.
Cox
A
A
Levy
A
A
Mayne
P
P
Lant
A F
AF
D000368:Aged; D045930:Anabolic Agents / Q000378:metabolism / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D008076:Cholesterol, HDL / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D015914:Estrogen Replacement Therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism; D008875:Middle Aged; D009652:Norpregnenes / Q000378:metabolism / Q000494:pharmacology*; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism
D045930:Anabolic Agents; D008076:Cholesterol, HDL; D009652:Norpregnenes; D012738:Sex Hormone-Binding Globulin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; C027385:tibolone